Connect Biopharma Holdings (CNTB) Change in Cash (2024 - 2026)

Connect Biopharma Holdings (CNTB) has reported Change in Cash for 3 consecutive years, with $7.7 million the latest figure, recorded in Q1 2026.

• Quarterly Change in Cash rose 125.19% year-over-year to $7.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.7 million (up 97.48% YoY) and the FY2025 annual result came in at -$39.9 million, down 45.41% from the prior year.
• Change in Cash climbed to $7.7 million in Q1 2026 per CNTB's latest filing, from $500000.0 in the prior quarter.
• Over the last five years, Change in Cash for CNTB reached as high as $8.4 million in Q1 2024 and fell as low as -$30.5 million in Q1 2025.
• A 3-year average of -$6.6 million and a median of -$4.3 million in 2024 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2025 — Change in Cash tumbled 461.73% — and 2026, when it soared 125.19%.
• Year by year, Change in Cash stood at -$19.0 million in 2024, then soared by 102.64% to $500000.0 in 2025, then surged by 1437.8% to $7.7 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $7.7 million, $500000.0, and -$2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.